Background: Chronic psychological stress is associated with increased intestinal epi-
| INTRODUC TI ON
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by abdominal discomfort or pain and changes in bowel habit. [1] [2] [3] Increasing evidence suggests that disturbance of the intestinal epithelial barrier function contributes to diarrhea-prone IBS-related symptoms. 4, 5 For example, the enhanced paracellular permeability is positively correlated with abdominal pain in IBS patients. 6 Recently, enhanced stress effects on gut barrier function have been implicated as a potential mechanism contributing to the pathophysiology of IBS. 7, 8 Chronic stress has significant effects on gut physiology and pathophysiology including alterations in gastrointestinal motility, enhanced visceral pain perception (hyperalgesia), and impaired intestinal barrier function in animal models 9,10 and IBS patients.
11,12
The corticoid receptor is one of the major players in mediating many physiological events in response to acute and chronic stress. 13, 14 The glucocorticoid receptor (GR), a ligand-activated transcription factor, depends on molecular chaperones for in vivo function. 15 After ligand binding, GR is translocated to the nucleus and binds to DNA on glucocorticoid response elements (GREs), recruiting transcriptional machinery and various coactivators and corepressors to positively or negatively regulate gene transcription.
GR translocation is mediated by the co-chaperone protein FK506
binding protein 5 (FKBP5) which is associated with the chaperone heat-shock protein 90 (Hsp90) to form a chaperon complex.
16,17
The Hsp90-GR complex, in its ATP-bound form, is stabilized by cochaperone p23, whereas heat-shock protein 70 (Hsp70) mediates GR complex assembly and activity. 15, 18 The importance of these chaperones has been established in the pathogenesis and therapy of stress and mental disorders. 14, 17, 19 In human colon epithelial cells, induction of Hsp70 expression displays a protective role in the epithelial barrier integrity which results in a decrease in paracellular permeability. 20 The augmentation of heat-shock proteins and reduced barrier integrity has been reported in colon tissues in an acute stress animal model. 21 The mechanism underlying how GR and its chaperones regulate intestinal paracellular permeability in chronic stress has not been determined.
Lubiprostone, a bicyclic fatty acid derived from prostaglandin E1 (PGE1), activates chloride channel type 2 (CIC-2) in the apical membrane of epithelial cells 22 and promotes the passage of water into the luminal space and bowel movements which can improve symptoms associated with constipation. 23, 24 CIC-2 channel plays an important role in the modulation of tight junctions by influencing caveolar trafficking of the tight junction protein occludin. 25 Targeted activation of CIC-2 chloride channels with lubiprostone stimulates repair of intestinal barrier function in the ischemia-injured porcine ileum and colon which is associated with impaired expression and function of tight junction proteins resulting in increased permeability. 26 However, it is unknown whether lubiprostone has a preventative effect on the increased permeability and enhanced visceral pain in animal models of chronic stress. The goal of the present study was to examine the hypothesis that lubiprostone prevents GR-mediated disruption of colon epithelial tight junction proteins and prevents increase of paracellular permeability and visceral pain.
| MATERIAL S AND ME THODS

| Animals and water avoidance (WA) stress
Male Sprague-Dawley rats (weighing 160-180 g) were obtained from Charles River Laboratories (Wilmington, MA, USA). Animals were housed in the animal facility that was maintained at 22°C with an automatic 12-hours light/dark cycle. The animals received a standard laboratory diet and tap water ad libitum. All experiments were approved by the University of Michigan Committee on Use and Care of Animals according to National Institutes of Health guidelines.
The animal study was conducted as shown in the following experimental scheme. Briefly, young-adult male rats were adapted in the animal facility for 3-5 days and then randomly grouped and subjected to 10-day WA stress as described previously. 27 The rats were placed on a glass platform in the middle of a tank filled with water (22°C) to 1 cm below the height of the platform. The animals were maintained on the tank for 1 hour in the morning (8 AM-10 AM) daily for 10 consecutive days. Lubiprostone (Takeda Pharmaceutical North America, Deerfield, IL, USA) was delivered orally instead of gavage to rats, to 
Key Points
• Chronic stress is associated with increased intestinal epithelial permeability and visceral hyperalgesia.
Lubiprostone accelerates intestinal epithelial repair. It is unknown how lubiprostone regulates colon epithelial barrier function and visceral pain in chronic stress.
• Lubiprostone prevented chronic stress-induced differential alterations of epithelial tight junction proteins, down-regulation of glucocorticoid receptor and its chaperones, and increase in paracellular permeability and visceral pain in the rodent and human.
• Our findings support a novel mechanism for lubiprostone to regulate intestinal permeability and visceral pain.
avoid distress or irritation, twice daily with 500 μL medium-chain triglycerides (MCT) as described. 28 A dose of 10 μg/kg body weight was suggested by the manufacturer and proved effective by a serial dose response pre-experiments. Rats were weighed each day for determination of the amount of lubiprostone delivered. All animals were treated with lubiprostone prior to stress procedure each day for a period of 10 days during the WA stress phase (WA+Lub group). MCT, the delivery medium for lubiprostone, was administrated similarly to the SHAM control (MCT-CT) rats and WA stress (MCT-WA) rats. The
MCT-CT rats were placed similarly for 1 hour daily for 10 days in a tank without water. The number of fecal output was recorded daily for each rat after 1 hour WA or SHAM stress. Behavioral assessments were conducted on the next day after completing the 10-day stress procedure. Separate groups of animals without behavioral measurements were used to harvest colon crypts from the distal colon, the same segment for balloon distention and visceral pain measurement.
The aliquots of isolated colon crypts were used for biochemical and molecular characterization. The experimenter was blinded to animal treatment during behavioral experiments.
| Visceral motor response (VMR) to colorectal distention (CRD)
Visceral pain measurement was conducted as previously described. 27, 29 Briefly, rats were deeply anesthetized with subcutaneous injection of a mixture of ketamine (60 mg/kg) and xylazine (5 mg/kg). An incision was made in the skin of the lower abdomen, and two perfluoroalkoxy-coated, 32-gauge stainless steel wires were inserted into the external oblique pelvic muscles superior to the inguinal ligament. Animals were injected with 500 µL of 0.9% saline, and artificial tears eye ointment was placed onto their eyes.
The animals were then allowed to recover for 3-5 days prior to the VMR measurement.
Measurement of the VMR to CRD was conducted in awake animals on day 11, next day after the completion of 10-day WA stress procedure. The VMR was quantified by measuring activity of electromyography (EMG) in the external oblique musculature in the awake animals. CRD was conducted to constant pressures of 10, 20, 40, and 60 mm Hg by a custom-made distension control device.
The responses were considered stable if there was <20% variability between 2 consecutive trials of CRD at 60 mm Hg. The increase in the area under curve (AUC), which is the sum of all recorded data points multiplied by the sample interval (in seconds) after baseline subtraction, was presented as the overall response during the course of the CRD test. 
| Cell culture and treatment
| Human colon crypts culture and treatment
Human colon crypts culture was conducted as described previously. 
| Measurement of transepithelial electrical resistance (TEER) and FITC-Dextran permeability
The TEER assay was used to measure the effect of treatments on the 3 mg/mL) was added to the upper chamber without medium change.
Aliquots were withdrawn from the lower chambers after 4 hours and assayed for fluorescence at 515 nm with excitation at 492 nm.
| Western blot analysis
Colon tissues in rats that had not undergone surgery or visceral pain measurement were dissected out next day after completing the 10-day WA stress procedure. The dissected colon segments were reversed inside-out and washed with 2 mmol/L DTT in cold PBS.
Then, tissues were incubated with 4 mmol/L EDTA in cold PBS for 5 minutes with shaking. The epithelium layers were gently scrapped off with a forceps and collected in PBS, followed by centrifugation at 500 g for 5 minutes. The crypts aliquots containing epithelium 
| Quantitative PCR (qPCR)
Total RNA from rat colon crypt aliquots was isolated using the 
| Chromatin Immunoprecipitation (ChIP)
Chromatin immunoprecipitation was performed using a chromatin immunoprecipitation kit (EMD Millipore, Billerica, MA, USA). Briefly, the colon crypt aliquots or Caco-2/BBE cells were cross-linked using 1%
formaldehyde and terminated by incubation with 0.125 mol/L glycine for 5 minutes. The cell lysate was incubated for 10 minutes at 4°C, and the crude nuclear extract was collected by centrifugation at 600 × g for 
| Immunofluorescence
FRC/TEX cells cultured on cover glasses were fixed for 30 minutes in 4% paraformaldehyde in 0.1 mol/L phosphate buffer. Cells were then permeabilized with 0.3% Triton X-100 for 1 hour and then blocked with 10% normal goat serum in PBS with 0.3% Triton X-100
for 4 hours at room temperature. Primary antibodies used for overnight incubation were anti-occludin (1:1000) and anti-ZO1 (1:5000).
Secondary antibodies Alexa Fluor 488 (1:500) and Alexa Fluor 594
(1:500) from Molecular Probes (Life Technologies) were used for incubation for 2 hour.
| Statistical analysis
To examine the VMR in response to CRD pressures, the EMG amplitudes, represented by calculating the AUC, were normalized as percentage of baseline response for the highest pressure (60 mm Hg) for each rat and then averaged for each group of rats. The effects of stress and/or lubiprostone treatment on the VMR to CRD were analyzed using a repeated-measures two-way ANOVA followed by Bonferroni posttest comparisons. Unpaired Student's t test was used to examine the data for protein, TEER, FITC-dextran, and ChIP assays. Results were expressed as means ± SEM P < 0.05 was considered statistically significant.
| RE SULTS
| Lubiprostone prevented chronic stress-induced visceral hyperalgesia in the rat
In our previous studies, we demonstrated that chronic WA stress induced visceral hyperalgesia which was largely blocked by GR receptor antagonist RU-486. 27, 35 It is unknown whether lubiprostone will have a preventative effect on chronic stress-associated visceral pain perception. In this study, we measured body weight gain, fecal pellet output and visceral pain in WA-stressed rats treated with lubiprostone or MCT vehicle. Intermittent 10-day WA stress induced a significant reduction in body weight gain in MCT-WA stress rats (29.0 ± 2.2 g) during this
10-day stress period compared to MCT-CT rats (43.5 ± 2.8 g) as shown
in Figure 1A (P < 0.001; n = 6-8). Lubiprostone treatment prevented stress-induced reduction in body weight gain. The average number of fecal pellet output during 1-hour stress each day was 0.78 ± 0.19 in MCT-CT rats, and it significantly increased to 4.1 ± 0.3 in MCT-WA rats (P < 0.001). Lubiprostone treatment did not affect the fecal pellet output compared to MCT-WA rats ( Figure 1B) . In MCT-WA rats, VMR in response to CRD, expressed as EMG activity, increased significantly to 111.6% ± 13.8% from the control level (64.9% ± 11.9%) of MCT-CT rats at 40 mm Hg pressure (P < 0.01; n = 6-8) and 244.3% ± 23.5% from the MCT-CT level (100.0% ± 9.2%) at 60 mm Hg pressure (P < 0.001; n = 6-8), respectively. In WA+Lub rats, VMR was significantly decreased to 72.8% ± 7.3% and 155.6% ± 38.7% at the distention pressures of 40 and 60 mm Hg, respectively, when compared to MCT-WA rat groups (P < 0.05). No differences in VMR to 10 and 20 mm Hg distention pressures were observed in these three animal groups ( Figure 1C ). MCT vehicle did not significantly influence VMR to CRD at any distention pressure when EMG amplitudes were compared between MCT-CT rats and healthy control rats without any treatment (data not shown).
| Lubiprostone blocked chronic stress-induced alterations of intestinal epithelial tight junction proteins in the rat colon
To test whether lubiprostone treatment affects intestinal epithelial tight junctions in chronic stress, we performed quantitative PCR and immunoblot using the acutely harvested rat colon crypts. As shown in Figure 2A , chronic WA stress significantly decreased mRNA levels of claudin-1, occludin, and GR receptor in the colon crypts in MCT-WA rats compared to MCT-CT rats (P < 0.05), while claudin-2 mRNA was significantly increased (P < 0.05). Lubiprostone treatment during the stress phase significantly increased mRNA levels of occludin and claudin-2 in this WA+Lub rat group compared to MCT-WA rats (P < 0.01), to the similar levels of MCT-CT rats, whereas it had modest effects on claudin-1 and GR receptor. Furthermore, Western blot showed that WA stress induced 49.0% ± 11.9% decrease in claudin-1 (P < 0.05), 73.8% ± 5.8% decrease in occludin (P < 0.01), and
37.2% ± 6.3% increase in claudin-2 protein (P < 0.05) in the MCT-WA rat colon crypts compared to MCT-CT rats, respectively. Treatment with lubiprostone significantly prevented the decreases of occludin but not claudin-1 and increase of claudin-2 protein in the rat colon.
The levels of occludin and claudin-2 in colon crypts in WA+Lub rats were reversed to 84.3% ± 5.1% (P < 0.05) and 61.9% ± 6.5% (P < 0.01) of their corresponding levels (100%) of MCT-CT rats, respectively, after lubiprostone treatment as shown in Figure 2B ,C. Consistent with the quantitative PCR result for claudin-1, lubiprostone had a modest reversal effect on chronic stress-induced down-regulation of claudin-1.
F I G U R E 1 Effect of lubiprostone (Lub) on chronic WA stressinduced visceral hyperalgesia in the rat. A, Body weight gain after 10-day WA or SHAM stress in rats treated with lubiprostone or MCT vehicle. B, Averaged number of fecal pellet output during 1 hour WA or SHAM stress period in MCT-CT, MCT-WA, and WA+Lub rat group. C, EMG amplitude, expressed as AUC of the VMR to CRD, was significantly increased following 10-day WA stress compared with the controls. Lubiprostone treatment largely prevented WA stressinduced increase in VMR to CRD at 40 and 60 mm Hg pressures. Data are expressed as mean ± SEM, n = 6-8 in each group. **P < 0.01; ***P < 0.001 for MCT-WA rats compared to the MCT-CT rats. #P < 0.05 for lubiprostone-treated stressed rats (WA+Lub) compared to MCT-WA rats without lubiprostone treatment.
| Effects of lubiprostone on cortisol-induced changes in tight junctions in human colon crypts and Caco-2/BBE cells
To test whether disruption of tight junctions observed in chronically stressed rats can be reproduced in human cells, differentiated Caco-2/ BBE cells and human colon crypts derived from healthy controls were treated with cortisol. The optimal dose for cortisol treatment was determined by treating cells with serial concentrations of cortisol for 24 hours. As shown in Figure 3A , occludin protein decreased in a dosedependent manner in these cells after cortisol treatment and the dose of 500 nmol/L cortisol was used for the subsequent experiments. As shown in Figure 3B ,C, cortisol treatment induced 53.8% ± 7.5% decrease in claudin-1 (P < 0.05), 45.5% ± 9.4% decrease in occludin (P < 0.05), and
171.3% ± 24.3% increase in claudin-2 (P < 0.01) compared with the control groups, respectively, in differentiated Caco-2/BBE cells after cortisol treatment. Lubiprostone significantly prevented these changes caused by cortisol. The protein levels of claudin-1, occludin, and claudin-2 were 125.5% ± 9.3%, 92.0% ± 5.3%, and 191.3% ± 32.9%, respectively, in cortisol-treated cells in the presence of lubiprostone compared to their corresponding control levels. The differences between cortisol-treated cells with and without lubiprostone were significant (P < 0.05). As shown in Figure 3D ,E, human colon crypts demonstrated 55.7% ± 4.4% decrease in claudin-1 (P < 0.01), 33.7% ± 9.9% decrease in occludin (P < 0.05), and 70.7% ± 13.5% increase in claudin-2 (P < 0.01), respectively, after cortisol treatment compared with the control groups.
Co-treatment with lubiprostone significantly prevented the decreases of claudin-1 and occludin and the increase of claudin-2. The levels of claudin-1, occludin, and claudin-2 in lubiprostone and cortisol treated were 73.8% ± 13.1%, 81.4% ± 7.04%, and 147.1% ± 8.6% of their corresponding control levels, respectively (P < 0.05).
| Effects of lubiprostone on paracellular permeability in Caco-2/BBE cells
In differentiated Caco-2/BBE cell monolayers, TEER was measured before and after treatment with cortisol in the presence and absence of lubiprostone, while FITC-dextran leakiness was measured after cortisol treatment with/without lubiprostone. As shown in Figure 4A , change of TEER decreased 24.9 ± 5.9 ohms/cm 2 in
Caco-2/BBE monolayers after cortisol treatment for 24 hours, whereas it increased 14.8 ± 7.1 ohms/cm 2 in the vehicle controls. The difference between these two groups was significant (P < 0.01; n = 18). In the presence of lubiprostone, change of TEER increased 28.4 ± 9.4 ohms/cm 2 in cortisol-treated cells, which was significantly different compared to those without lubiprostone co-treatment (P < 0.001; n = 18). Moreover, FITC-dextran measurement in the differentiated Caco-2/BBE monolayers showed 40.7% ± 2.5% increase in the intensity of 4 kDa FITC-dextran in the lower chamber of the Transwell cell cultures compared to the controls (P < 0.01; n = 12). This enhancement was reduced significantly to 122.7% ± 4.8% of the control by treatment with lubiprostone (P < 0.01; Figure 4B ).
| Lubiprostone prevented cortisol-induced down-regulation of GR in human samples
We reported previously that GR was down-regulated after cortisol treatment in Caco-2/BBE cells. 34 Here, we examined F I G U R E 2 Lubiprostone treatment differentially altered epithelial tight junction protein expression in the rat colon in chronic stress. A, Quantitative PCR analysis of the expression levels of tight junction genes including claudin-1, claudin-2, and occludin and the expression of GR receptor in colon crypts of MCT-WA rats compared to MCT-CT rats in the presence and absence of lubiprostone. B, Immunoblot for detection of claudin-1, claudin-2, and occludin proteins in the colon crypts in MCT-CT, MCT-WA, and WA+Lub rats. C, Bar graph depicting the relative protein levels of claudin-1, claudin-2, and occludin in WA+Lub rats compared to MCT-WA rats and MCT-CT rats. n = 4-6 of each group. *P < 0.05; **P < 0.01 for MCT-WA rats compared to MCT-CT rats. #P < 0.05; ##P < 0.01 for WA+Lub rats compared to MCT-WA rats without lubiprostone treatment.
whether lubiprostone treatment altered GR expression. As shown in Figure 5A , the protein level of GR in differentiated Caco-2/BBE cells was significantly decreased to 36.6% ± 4.7%
after cortisol treatment for 24 hours (P < 0.01). Administration of lubiprostone during cortisol treatment reversed GR expression to 52.6% ± 7.5% of the untreated level (P < 0.05). Similarly, GR protein expression decreased 64.1% ± 5.3% in acutely harvested human colon crypts after cortisol treatment for 24 hours (P < 0.01) as shown in Figure 5B . Lubiprostone significantly reversed GR protein level to 113.5% ± 10.9% of the untreated control (P < 0.01). In addition, we examined GR protein levels in colon crypts from rats subjected to 10-day WA stress with/without lubiprostone. As shown in Figure 5C , GR protein was significantly decreased in colon crypts in MCT-WA rats compared to MCT-CT rats (P < 0.001; n = 5). Lubiprostone treatment partially reserved GR protein level (to 70.6% ± 21.5%) in WA+Lub group compared to the level of 40.1% ± 14.4% in MCT-WA group.
The difference between these two groups was not significant (P = 0.137; n = 5).
| Lubiprostone reversed cortisol-induced downregulation of GR co-chaperones
We examined GR chaperon proteins in differentiated Caco-2/BBE cells to test the hypothesis that GR function can be regulated by lubiprostone. As shown in Figure 6 , both cortisol and lubiprostone did not alter the levels of GR chaperon proteins Hsp90 and Hsp70. In contrast, GR co-chaperon proteins p23 and FKBP5 were significantly decreased to 40.7% ± 6.6% (P < 0.01) and 79.8% ± 10.5% (P < 0.05) of the control levels, respectively, in Caco-2 cells treated by cortisol.
Lubiprostone co-treatment significantly blocked cortisol-induced down-regulation of p23 and FKBP5, suggesting the regulatory effect of lubiprostone on GR expression and function.
| Lubiprostone inhibited cortisol-induced decrease in GR binding to occludin gene promoter
Next, we tested whether the binding of GR, as a positive transcription factor, to occludin promoter regions was affected by cortisol and 
| Lubiprostone prevented corticosteroneinduced alterations of GR chaperon protein in the rat colonic cells
In rat colonic FRC/TEX cells, occludin expression and localization were significantly disrupted after corticosterone treatment and this change was prevented by lubiprostone treatment ( Figure 8A ). In contrast, ZO-1 expression and localization were not altered by cortisol treatment. As shown in Figure 8B , GR protein level was decreased in corticosterone-treated FRC/TEX cells which was largely reversed by lubiprostone, whereas MR was not affected by corticosterone.
Corticosterone had no significant effect on GR chaperon protein Hsp90, but decreased protein levels of GR co-chaperon proteins p23
and FKBP5. Lubiprostone treatment normalized the down-regulation of p23 and FKBP5 in these cells.
| D ISCUSS I ON
In this study, we revealed a novel role for lubiprostone to amelio- in the rats 9 and that chronic stress resulted in impairment of intestinal barrier function and visceral hyperalgesia. 9, 10 It has been reported that claudin-2, which is sensitive to stressful conditions, is involved in paracellular water transport and contributes 23%-30% of the total water transport in proximal kidney tubules. 42, 43 The expression of pore-forming claudin-2 could be induced by tumor necrosis factor-neuropeptide Y "cross-talk" in vitro which was associated with increased epithelial permeability in inflammation. 44 In normal colon, claudin-2 is highly expressed in the crypt bottom containing the undifferentiated and proliferative colonocytes. 45 However, the detailed function of claudin-2 in the colon is largely unknown, particularly under chronic stress conditions. We hypothesize that chronic stress-induced up-regulation of claudin-2 in the colon can lead to increased water secretion and epithelial permeability and that prevention of claudin-2 increase by lubiprostone can normalize chronic stress-induced disruption of intestinal barrier function. It has been F I G U R E 5 Effects of lubiprostone on GR receptor protein expression in differentiated Caco-2/BBE cells, human colon crypts, and stressed rats. A, Protein expression of GR receptor in 21-day cultured Caco-2/BBE cells treated by cortisol (500 nmol/L) and lubiprostone (100 nmol/L) for 24 hours. B, Cortisol treatment (500 nmol/L; 24 hours) significantly decreased GR protein level in human colon crypts. Lubiprostone (100 nmol/L) prevented cortisol-induced down-regulation of GR receptor. C, GR protein expression in colon crypts isolated from MCT-CT, MCT-WA, and WA+Lub rat groups. n = 3-5. **P < 0.01 for cortisoltreated group compared to the controls. ***P < 0.01 for MCT-WA rats compared to MCT-CT rats. #P < 0.05; ##P < 0.01 for cortisol and lubiprostone-treated group compared to the cortisol-treated group.
F I G U R E 6 Differential effects of cortisol and lubiprostone on the alterations of GR chaperone proteins in differentiated Caco-2/BBE cells. A, Immunoblots for probing the express levels of GR chaperone and co-chaperone proteins including Hsp90, Hsp70, p23, and FKBP5 in 21-day cultured Caco-2/BBE cells in the presence and absence of cortisol (500 nmol/L; 24 hours) and lubiprostone (100 nmol/L; 24 hours). B, Statistical bar graph showed that cortisol treatment decreased p23 and FKBP5 in Caco-2/BBE cells and lubiprostone treatment largely blocked down-regulation of p23 and FKBP5 induced by cortisol. n = 3. *P < 0.05; **P < 0.01 for cortisol-treated cells compared to the controls. #P < 0.05; ##P < 0.01 for cortisol and lubiprostone-treated group compared to the cortisol-treated group.
reported that claudin-2 is increased in the jejunum in IBS with diarrhea, 46 supporting an important role of this tight junction protein in regulation of intestinal barrier function.
In our previous study, we observed significant decrease in GR receptor expression in colon epithelial cells in the stressed and corticosterone-treated rats, which was largely blocked by corticoid receptor antagonist RU-486. 9 In this study, we further demonstrated that GR protein was down-regulated in differentiated Caco-2/BBE cells and normal human colon crypts after cortisol treatment that was associated with increased paracellular permeability, suggesting a role for GR in modulation of tight junction protein expression and function. These results are consistent with other studies using in vitro cell lines. 47, 48 Our ChIP-qPCR analysis showed that GR could directly bind to occludin promoter and this GR binding was decreased the Hop and p23 co-chaperones. 15 In our study, both Hsp90 and previous report that FKBP5 links to the development of posttraumatic stress disorder (PTSD) and was found to be less expressed in PTSD. 50 These data strongly support a function of FKBP5 as a modulator of the response to stressful life events. It is very likely that FKBP5 functions in chronic stress through its action in GR resistance and translocation. 17 Accordingly, down-regulation of GR altered the transcription and expression of epithelial tight junction proteins and disrupted barrier function under chronic stress conditions and subsequently induced visceral hyperalgesia in stressed animals. However, the exact mechanism underlying how these co-chaperones modulate GR ligand binding and translocation to the nucleus in colon epithelial cells in chronic stress remains to be elucidated.
It has been reported that lubiprostone significantly improves symptoms in patients with chronic constipation 51 and is more effective than placebo in improving abdominal pain or bloating in IBS patients with constipation. 52 The signal trans- 
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